This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: The University of Chicago. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Joseph Piccirilli: Innovator in Cancer Treatment
Introduction
Joseph Piccirilli is a notable inventor based in Chicago, IL, who has made significant contributions to the field of cancer treatment. His innovative work focuses on receptor-mediated delivery systems that enhance the effectiveness of therapeutic agents in targeting cancer cells.
Latest Patents
Joseph Piccirilli holds a patent for "Receptor-mediated delivery: compositions and methods." This patent outlines compositions and methods for delivering an agent to a cell that comprises a prolactin receptor. The invention includes a method for inhibiting breast, ovarian, or prostate cancer cells by contacting the cells with a complex that includes a prolactin receptor ligand linked to various therapeutic agents. Additionally, methods for detecting cancer cells expressing a prolactin receptor are also provided in this patent.
Career Highlights
Joseph Piccirilli is affiliated with The University of Chicago, where he continues to advance research in cancer therapies. His work is characterized by a commitment to developing innovative solutions that can potentially improve patient outcomes in oncology.
Collaborations
Throughout his career, Joseph has collaborated with esteemed colleagues such as Ernst Lengyel and Anthony A Kossiakoff. These collaborations have further enriched his research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Joseph Piccirilli's contributions to cancer treatment through innovative receptor-mediated delivery systems highlight his role as a leading inventor in the field. His work not only showcases his expertise but also holds promise for future advancements in cancer therapies.